Filter Results:
- Full text PDF available (16)
Publication Year
1994
2018
- This year (1)
- Last 5 years (21)
- Last 10 years (44)
Publication Type
Co-author
Journals and Conferences
Learn More
- Olga Mediano, Antònia Barceló, Marlon de la Peña, David Gozal, Alvar Agustí, Françoise Barbé
- The European respiratory journal
- 2007
Excessive daytime sleepiness (EDS) is not invariably present in patients with obstructive sleep apnoea syndrome (OSAS). The aim of the present study was to investigate polysomnographic determinants… (More)
- Núria Roure, Silvia Gonzalez Gomez, +13 authors Ferran Barbé
- Sleep medicine
- 2008
BACKGROUND
Excessive daytime sleepiness (EDS) is the major complaint in subjects with obstructive sleep apnea syndrome (OSAS). However, EDS is not universally present in all patients with OSAS. The… (More)
- Ferran Barbé, Joaquín Durán-Cantolla, +15 authors Josep María Montserrat
- JAMA
- 2012
CONTEXT
Continuous positive airway pressure (CPAP) is the first-line treatment for patients with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with… (More)
- Maria R Bonsignore, Cristina Esquinas, +5 authors Ferran Barbé
- The European respiratory journal
- 2012
The metabolic syndrome shows a variable prevalence in obstructive sleep apnoea (OSA), and its association with insulin resistance or excessive daytime sleepiness in OSA is unclear. This study… (More)
- M. de la Peña, Antònia Barceló, +5 authors Alvar Agustí
- Respiration; international review of thoracic…
- 2008
BACKGROUND
Endothelial dysfunction and cardiovascular diseases are frequent in patients with obstructive sleep apnea (OSA). Circulating endothelial progenitor cells (EPCs) contribute to repair… (More)
- Antònia Barceló, M A Elorza, Françoise Barbé, Carmen Lucia Ruybal dos Santos, Lola R Mayoralas, Alvar Agustí
- The European respiratory journal
- 2001
The prevalence of several cardiovascular diseases is increased with obstructive sleep apnoea syndrome (OSAS), due to, as yet, unclear reasons. Angiotensin converting enzyme (ACE) abnormalities have… (More)
- Antònia Barceló, Cristina Miralles, Ferran Barbé, M. T. Butron Vila, Salvador Pons, Alvar Agustí
- The European respiratory journal
- 2000
The prevalence of cardiovascular diseases is increased in patients with the obstructive sleep apnoea syndrome (OSAS). The fall and rise of arterial oxygenation that follows each apnoea may increase… (More)
- Antònia Barceló, Ferran Barbé, +4 authors Alvar Agustí
- The American journal of medicine
- 2004
- Manuel Sánchez-de-la-Torre, Abdelnaby Khalyfa, +12 authors Ferran Barbé
- Journal of the American College of Cardiology
- 2015
BACKGROUND
In patients with resistant hypertension (RH) and obstructive sleep apnea (OSA), the blood pressure response to continuous positive airway pressure (CPAP) treatment is highly variable and… (More)
- Xavier Busquets, Ferran Barbé, +5 authors Alvar Agustí
- Respiration; international review of thoracic…
- 2004
BACKGROUND
Orexin-A, also known as hypocretin, is a neuropeptide implicated in appetite and sleep regulation. Because the obstructive sleep apnea syndrome (OSAS) is characterized by obesity and… (More)